Immunocompromised patients and coronavirus disease 2019: a review and recommendations for dental health care

Abstract In less than four months, an unprecedented pandemic changed the world scenario, closing institutions and commerce, paralyzing sports championships, blocking frontiers, and putting almost all populations in a house quarantine regimen. Immunocompromised patients are within the high-risk group to severe outcomes from COVID-19. However, there is no clear evidence of the association between impaired immune host status and complications from SARS-CoV-2 infection so far. The virus is transmitted by inhalation or direct contact with infected secretions, and therefore the dental office is a highly susceptible environment for such transmission. Here, we review the literature and discuss immunological COVID-19 related issues. We also make suggestions for immunocompromised patients’ support in this new emerging context of clinical dental practice. Until comprehensive findings are published, individuals with impaired immunity should be considered as high-risk. Cross infection control procedures for the clinical care of immunocompromised patients should follow the same guidelines that are being proposed for immunocompetent ones. However, during the active outbreak, people under immunosuppressive conditions should not receive elective procedures, even if they do not have symptoms or exposure history to COVID-19, and in case of emergence, care must be done in a separate airborne room. In the pos-pandemic phase, the dental care general recommendations should be the same for all subjects. Changes in the current guidelines have been proposed to SARS-CoV-2 infection control in order to provide the best and safe dental practice. However, they still need to be validated by future studies.

Saved in:
Bibliographic Details
Main Authors: MARTINS-CHAVES,Roberta Rayra, GOMES,Carolina Cavaliéri, GOMEZ,Ricardo Santiago
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Pesquisa Odontológica - SBPqO 2020
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-83242020000100601
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1806-83242020000100601
record_format ojs
spelling oai:scielo:S1806-832420200001006012020-05-11Immunocompromised patients and coronavirus disease 2019: a review and recommendations for dental health careMARTINS-CHAVES,Roberta RayraGOMES,Carolina CavaliériGOMEZ,Ricardo Santiago Coronavirus Infections COVID-19 Immunosuppression Dental Care Dentistry Abstract In less than four months, an unprecedented pandemic changed the world scenario, closing institutions and commerce, paralyzing sports championships, blocking frontiers, and putting almost all populations in a house quarantine regimen. Immunocompromised patients are within the high-risk group to severe outcomes from COVID-19. However, there is no clear evidence of the association between impaired immune host status and complications from SARS-CoV-2 infection so far. The virus is transmitted by inhalation or direct contact with infected secretions, and therefore the dental office is a highly susceptible environment for such transmission. Here, we review the literature and discuss immunological COVID-19 related issues. We also make suggestions for immunocompromised patients’ support in this new emerging context of clinical dental practice. Until comprehensive findings are published, individuals with impaired immunity should be considered as high-risk. Cross infection control procedures for the clinical care of immunocompromised patients should follow the same guidelines that are being proposed for immunocompetent ones. However, during the active outbreak, people under immunosuppressive conditions should not receive elective procedures, even if they do not have symptoms or exposure history to COVID-19, and in case of emergence, care must be done in a separate airborne room. In the pos-pandemic phase, the dental care general recommendations should be the same for all subjects. Changes in the current guidelines have been proposed to SARS-CoV-2 infection control in order to provide the best and safe dental practice. However, they still need to be validated by future studies.info:eu-repo/semantics/openAccessSociedade Brasileira de Pesquisa Odontológica - SBPqOBrazilian Oral Research v.34 20202020-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-83242020000100601en10.1590/1807-3107bor-2020.vol34.0048
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author MARTINS-CHAVES,Roberta Rayra
GOMES,Carolina Cavaliéri
GOMEZ,Ricardo Santiago
spellingShingle MARTINS-CHAVES,Roberta Rayra
GOMES,Carolina Cavaliéri
GOMEZ,Ricardo Santiago
Immunocompromised patients and coronavirus disease 2019: a review and recommendations for dental health care
author_facet MARTINS-CHAVES,Roberta Rayra
GOMES,Carolina Cavaliéri
GOMEZ,Ricardo Santiago
author_sort MARTINS-CHAVES,Roberta Rayra
title Immunocompromised patients and coronavirus disease 2019: a review and recommendations for dental health care
title_short Immunocompromised patients and coronavirus disease 2019: a review and recommendations for dental health care
title_full Immunocompromised patients and coronavirus disease 2019: a review and recommendations for dental health care
title_fullStr Immunocompromised patients and coronavirus disease 2019: a review and recommendations for dental health care
title_full_unstemmed Immunocompromised patients and coronavirus disease 2019: a review and recommendations for dental health care
title_sort immunocompromised patients and coronavirus disease 2019: a review and recommendations for dental health care
description Abstract In less than four months, an unprecedented pandemic changed the world scenario, closing institutions and commerce, paralyzing sports championships, blocking frontiers, and putting almost all populations in a house quarantine regimen. Immunocompromised patients are within the high-risk group to severe outcomes from COVID-19. However, there is no clear evidence of the association between impaired immune host status and complications from SARS-CoV-2 infection so far. The virus is transmitted by inhalation or direct contact with infected secretions, and therefore the dental office is a highly susceptible environment for such transmission. Here, we review the literature and discuss immunological COVID-19 related issues. We also make suggestions for immunocompromised patients’ support in this new emerging context of clinical dental practice. Until comprehensive findings are published, individuals with impaired immunity should be considered as high-risk. Cross infection control procedures for the clinical care of immunocompromised patients should follow the same guidelines that are being proposed for immunocompetent ones. However, during the active outbreak, people under immunosuppressive conditions should not receive elective procedures, even if they do not have symptoms or exposure history to COVID-19, and in case of emergence, care must be done in a separate airborne room. In the pos-pandemic phase, the dental care general recommendations should be the same for all subjects. Changes in the current guidelines have been proposed to SARS-CoV-2 infection control in order to provide the best and safe dental practice. However, they still need to be validated by future studies.
publisher Sociedade Brasileira de Pesquisa Odontológica - SBPqO
publishDate 2020
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-83242020000100601
work_keys_str_mv AT martinschavesrobertarayra immunocompromisedpatientsandcoronavirusdisease2019areviewandrecommendationsfordentalhealthcare
AT gomescarolinacavalieri immunocompromisedpatientsandcoronavirusdisease2019areviewandrecommendationsfordentalhealthcare
AT gomezricardosantiago immunocompromisedpatientsandcoronavirusdisease2019areviewandrecommendationsfordentalhealthcare
_version_ 1756431667102220288